Science Explorer Interactive view Map
Company · Mumbai · India

Sanofi (India)

Research works
68
▲ 225% vs 2013–17
Citations
1.1k
15.7 per fractional work
Top-10% rate
14.7%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Sanofi (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.53× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.84× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 11.00× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.07× its world share, 1 worksChemistryComputer Science: 0.23× its world share, 0 worksComputer ScienceEngineering: 0.07× its world share, 0 worksEngineeringMathematics: 7.30× its world share, 2 worksMathematicsDentistry: 1.86× its world share, 0 worksDentistryHealth Professions: 1.70× its world share, 1 worksHealth ProfessionsMedicine: 2.50× its world share, 9 worksMedicineNursing: 0.92× its world share, 0 worksNursingVeterinary: 13.32× its world share, 0 worksVeterinaryDecision Sciences: 7.47× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.23× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.02× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Veterinary, 13.3×. Every wedge is a field page.

Which keywords describe research at Sanofi (India)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Glycemic Control, Pathogenesis, Insulin Therapy, Clinical Guidelines, Cardiovascular Disease, Diabetes and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology9▲ 3.1×31 topics
  2. Cardiovascular Disease4▲ 5.0×6 topics
  3. Glycemic Control4▲ 41×4 topics
  4. Insulin Therapy4▲ 49×3 topics
  5. Pathogenesis4▲ 9.8×12 topics
  6. Clinical Guidelines3▲ 15×5 topics
  7. Inflammation3▲ 1.95×14 topics
  8. Diabetes3▲ 8.7×6 topics
  9. Quality of Life3▲ 3.0×7 topics
  10. Clinical Trials3▲ 6.4×8 topics
  11. Immunity2▲ 11×4 topics
  12. Type 1 Diabetes2▲ 40×2 topics
  13. Complications2▲ 6.5×4 topics
  14. Vaccine2▲ 8.1×8 topics
  15. Genetics2▲ 4.0×9 topics
  16. Heart Failure2▲ 6.7×5 topics
  17. Continuous Glucose Monitoring2▲ 64×1 topic
  18. Hypoglycemia2▲ 64×1 topic
  19. Drug Delivery2▲ 5.5×4 topics
  20. Global Burden2▲ 4.8×6 topics
  21. Pharmacokinetics2▲ 9.8×5 topics
  22. Quality Assessment2▲ 14×3 topics
  23. Adverse Drug Reactions2▲ 39×2 topics
  24. Economic Evaluation2▲ 19×2 topics
  25. Publication Bias2▲ 46×2 topics
  26. Cost-effectiveness Analysis2▲ 31×1 topic
  27. Diabetes Mellitus2▲ 10×4 topics
  28. Health Utility Measures2▲ 31×1 topic
  29. Nasal2▲ 46×2 topics
  30. Pharmaceutical Industry2▲ 57×2 topics
  31. Type 2 Diabetes2▲ 12×3 topics
  32. Cardiovascular Outcomes1▲ 48×1 topic
  33. Chitosan1▲ 38×1 topic
  34. Glucose Control1▲ 48×1 topic
  35. Molecular Mechanisms1▲ 11×2 topics
  36. Mucosal1▲ 76×1 topic
  37. Treatment Guidelines1▲ 9.6×4 topics
  38. Anesthesia1▲ 17×3 topics
  39. Diagrid Structures1▲ 416×1 topic
  40. Ground Motion1▲ 67×1 topic

Which research topics does Sanofi (India) publish most on?

By volume in 2022–2025: Meta-analysis and systematic reviews, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life and Multiple Myeloma Research and Treatments.

  1. 1 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 1 works
  2. 2 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  4. 4 Multiple Myeloma Research and Treatments Hematology 0 works
  5. 5 Advanced Statistical Methods and Models Statistics and Probability 0 works
  6. 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Diabetes and associated disorders Genetics 0 works
  9. 9 Protein purification and stability Molecular Biology 0 works
  10. 10 Adipose Tissue and Metabolism Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.5%not open47.5%

World: 28% of research is openly available.

with international co-authors26.1%domestic only73.9%

World: 19% is written across borders.

How has Sanofi (India)'s research output changed?

Output in 2018–2022 was 225% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mumbai

All research institutions in Mumbai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.